SARS-CoV 2, SARS Pneumonia
Conditions
Brief summary
This study seeks to assess the impact of physical and pulmonary rehabilitation on patients who have been diagnosed with COVID-19 in the short and long term in hopes of establishing a best practices protocol for treatment of future patients with this disease.
Detailed description
The novel coronavirus that began in Wuhan, China in late 2019 made an appearance in the United States in January 2020. It is a respiratory disease spreading rapidly from person to person. Recent data shows that fibrosis is seen on the lungs, and possible myocardial damage. Data shows that physical therapy was not highly utilized in recovery for these patients due to high PPE demands, and increased risk of exposure. This study will be using telehealth services to assess and treat these patients so Physical Therapy guidance is provided for movement and returning to prior level of function. Currently there is no data showing the long term effects of the those who were able to utilize Physical Therapy in recovering from COVID-19 This study will be looking at the differences in outcomes of COVID-19 positive subjects who able to complete Physical Therapy Telehealth visits versus those who did not. All groups will be tested at multiple data points for lung capacity, upper and lower extremity strength, and overall endurance to determine the long term functional effects. The control group were diagnosed with COVID-19 and recovered before the Physical and Pulmonary protocol was implemented.
Interventions
BEHAVIORALTherapy Intervention
Patients receive 2-4 visits (based on patient presentation and need) of physical therapy, up to 4 visits of occupational therapy, up to 4 visits of speech therapy based on need. Treatment focuses on physical strengthening, pulmonary strengthening/breathing exercises, and cognitive rehabilitation.
Sponsors
University of Missouri-Columbia
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)
Masking description
Participants and care providers will know which group they are in, but data will be deidentified and blinded prior to analysis or viewing by the primary investigator
Intervention model description
Patients receiving care through the program developed by the University of Missouri Healthcare system will, if willing, return for follow up testing and be compared against a matched group that did not receive the rehabilitative treatment to see if there are short or long term differences.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* \>Age of 18 * Positive COVID-19 diagnosis in the last 6 months
Exclusion criteria
* Age of \<18
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in 6 Minute Walk Test | From 6 to 24 months post diagnosis | Validated test demonstrating functional gait capacity and endurance; measuring change in capacity over time in 6 month increments. |
| Change in Short Form 35 (SF-36) Questionnaire | From 6 to 24 months post diagnosis | Validated questionnaire assessing function and quality of life for patients with pulmonary function issues |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Strength testing | From 6 to 24 months post diagnosis | Use of grip dynamometer and isokinematic lower extremity testing to determine muscle capacity |
| Change in Peak Flow Meter Test | From 6 to 24 months post diagnosis | Measures lung output capacity |
Countries
United States
Outcome results
None listed